DH
Definitive Healthcare Corp - Ordinary Shares - Class A

164
Mkt Cap
$390.96M
Volume
322,862.00
52W High
$5.68
52W Low
$2.15
PE Ratio
-1.60
DH Fundamentals
Price
$2.69
Prev Close
$2.76
Open
$2.75
50D MA
$3.17
Beta
1.21
Avg. Volume
280,746.70
EPS (Annual)
-$3.54
P/B
0.97
Rev/Employee
$322,508.95
Loading...
Loading...
News
all
press releases
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Recommendation of "Hold" by Analysts
Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has been assigned a consensus rating of "Hold" from the nine ratings firms that are presently covering the company, MarketBeat Ratings...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Has $1.41 Million Stake in Definitive Healthcare Corp. $DH
Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 44.3% in the 2nd quarter, according to its most recent 13F filing...
MarketBeat·7d ago
News Placeholder
Definitive Healthcare (NASDAQ:DH) Price Target Lowered to $4.00 at Canaccord Genuity Group
Canaccord Genuity Group dropped their target price on shares of Definitive Healthcare from $5.00 to $4.00 and set a "hold" rating on the stock in a report on Monday...
MarketBeat·13d ago
News Placeholder
Definitive Healthcare (NASDAQ:DH) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS
Definitive Healthcare (NASDAQ:DH - Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate...
MarketBeat·15d ago
News Placeholder
Definitive Healthcare (NASDAQ:DH) Releases Q4 2025 Earnings Guidance
Definitive Healthcare (NASDAQ:DH) updated its fourth quarter 2025 earnings guidance. The company provided EPS guidance of 0.050-0.060 for the period, compared to the consensus estimate of 0.050. The...
MarketBeat·17d ago
News Placeholder
Definitive Healthcare (NASDAQ:DH) Issues FY 2025 Earnings Guidance
Definitive Healthcare (NASDAQ:DH) updated its FY 2025 earnings guidance. The company provided EPS guidance of 0.230-0.240 for the period, compared to the consensus estimate of 0.170. The company also...
MarketBeat·17d ago
News Placeholder
Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates
Definitive Healthcare (DH) delivered earnings and revenue surprises of +16.67% and +1.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
NCR Atleos (NATL) Q3 Earnings and Revenues Beat Estimates
NCR Atleos (NATL) delivered earnings and revenue surprises of +7.92% and +0.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19d ago
News Placeholder
Thryv Holdings, Inc. (THRY) Q3 Earnings Miss Estimates
Thryv (THRY) delivered earnings and revenue surprises of -46.51% and +0.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·26d ago
News Placeholder
What Makes Definitive Healthcare (DH) a New Buy Stock
Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·1mo ago

Latest DH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.